Table 1.
Compds | Gram-positive bacteria | Gram-negative bacteria | |||||
---|---|---|---|---|---|---|---|
B. subtilis | S. aureus | M. luteus | P. aeruginosa | E. coli | A. baumannii | ||
| |||||||
ATCC 6633 |
SG 511 | ATCC 10240 | K799/wt | K799/61 | X580 | ATCC 17961a | |
Ciprofloxacin | 28c | 28b | 12Pb | 21c | 24/32pc | 31d | 15pb |
13 | 34 | 25 | 14 | 27/31P | 31/46P | 34/38P | NT |
24 | 26 | 22 | 0 | 18P | 19/26P | 32/39P | NT |
23 | 20/26p | 13P | 0 | 19 | 19/26p | 27 | 20 |
25 | 0 | 0 | 0 | 14 | 0 | 21 | 18 |
p, partially clear inhibition zone/colonies in the inhibition zone; P, unclear inhibition zone/many colonies in the inhibition zone; NT, not tested
Exactly 50 µL of a 0.2 mM solution of each compound dissolved in 1:9 DMSO/MeOH was filled in 9 mm wells in agar media (Mueller Hinton II). Inhibition zones read after incubation at 37 °C for 24 h.
A. baumannii was tested in the presence of 100 µM of 2,2’-bipyridine.
Ciprofloxacin was tested at (b) 5 µg/mL, (c) 1.66 µg/mL, (d) 0.33 µg/mL in H2O.